Up next
Share article
The post has been shared by 0 people.
Mail 0
LinkedIn 0
Twitter 0

DCAT Value Chain Insights Bonus Coverage: From DCAT Week 2024: Supplier News Roundup 

What other DCAT Member Companies are making the news? A roundup of the latest developments from CDMOs/CMOs and other suppliers in drug-substance (small molecules & biologics) and drug-product development and manufacturing and packaging.

What other DCAT Member Companies are making the news? A roundup of the latest developments from CDMOs/CMOs and other suppliers in drug-substance (small molecules & biologics) and drug-product development and manufacturing and packaging. 

Companies making the news 
Here is a roundup of recent news announcements from DCAT Member Companies across the bio/pharmaceutical manufacturing value chain: from active pharmaceutical ingredients (small molecules and biologics) to drug products (solid dosage, injectables and specialty dosage forms), and packaging.  
 
See related stories and the companies making the news below:   

From DCAT Week 2024: Supplier News: Chemicals/Chemical API Manufacturing
Featuring news from Olon, Grace, PharmaBlock, Axplora, ChemCon, Suven Pharma and The Solubility Company. 

From DCAT Week 2024: Supplier News: Biologics Manufacturing
Featuring news from Siegfried and Solvias. 

From DCAT Week 2024: Supplier News: Formulation Development/Drug Product Manufacturing 
Featuring news from Alcami, Corealis Pharma, Curia, Delpharm and Grand River Aseptic Manufacturing. 

From DCAT Week 2024: Supplier News: End-to-End (Drug Substance and Drug Product)
Featuring news from Lonza and Mabion.  

From DCAT Week 2024: Supplier News: Packaging 
Featuring news from Adare Pharma Solutions and ApiJect 

Recent Feature Articles

DCAT Week 2025: Pharma Industry Outlook: Is There Growth or Not?

By
How did the bio/pharma industry perform in 2024, and what is the outlook for 2025 and near term?  What are the key growth areas and what headwinds and tailwinds does the industry face? How will new modalities factor into the growth prospects? Industry experts at DCAT Week 2025 provide the answers.

DCAT Week 2025: Manufacturing, Metrics, & the Supply Chain

By
How are bio/pharma companies and their suppliers tackling difficult challenges in development, manufacturing, and the supply chain, including in risk management? How is supplier relationship management evolving? Senior executives at the education programs at DCAT Week will provide key insights.

CDMO/CMO Outlook: Fill-Finish: A Capacity Crunch or Capacity Easing? 

By
What is the supply-demand outlook for fill–finish capacity in the CDMO/CMO sector? Is a capacity crunch or capacity easing in the making?

DCAT Week 2025: Achieving Supply Chain Resiliency Amid Geopolitical Risk

By
Evolving trade-related issues, such as tariffs, is one of many external variables that factor into the calculus in risk management. An executive panel at an upcoming DCAT Week program will provide perspectives on approaches to best identify, respond, and mitigate risk arising from geopolitical and other external events.